NCT05103410View on ClinicalTrials.gov

Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 10, 2021

Primary Completion Date

January 1, 2023

Study Completion Date

January 10, 2023

Conditions
AnesthesiaAnalgesiaHysterotomy
Interventions
DRUG

ARIPiprazole 30 MG

Patients will receive Aripiprazole 30 mg tablet orally 3 h before surgery

DRUG

Placebo

Patients will receive placebo tablet which is identical in appearance, size, shape, and color to aripiprazole 3 h before surgery

Trial Locations (1)

Unknown

Ain Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05103410 - Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy | Biotech Hunter | Biotech Hunter